A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells

Journal of Heart and Lung Transplantation

Volumn 29, Issue 5, 2010, Pages 574-577

  Rupp, Stefan ^a   Zeiher, Andreas M ^b   Dimmeler, Stefanie ^b   Tonn, Torsten ^c   Bauer, Juergen ^a   Jux, Christian ^a   Akintuerk, Hakan ^a   Schranz, Dietmar ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Institute of Transfusion Medicine and Immunohaematology   (Germany)

Author keywords

autologous stem cell therapy; heart failure; HLHS

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; ERYTHROPOIETIN; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IRBESARTAN; LISINOPRIL; SILDENAFIL; SPIRONOLACTONE;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CARDIOGENIC SHOCK; CASE REPORT; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; LUNG ARTERY BANDING; MITRAL VALVE STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT; TRICUSPID VALVE REGURGITATION;

BONE MARROW TRANSPLANTATION; COMPASSIONATE USE TRIALS; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; POSTOPERATIVE COMPLICATIONS; REGENERATION; REOPERATION; STEM CELL TRANSPLANTATION;

EID: 77950521500     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.10.006     Document Type: Article

References (18)

1. Jessup M., Abraham W.T., Casey D.E., et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (2009) 1977-2016
2. Rosenthal D., Chrisant M.R., Edens E., et al. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant 23 (2004) 1313-1333
3. Canter C.E., Shaddy R.E., Bernstein D., et al. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 115 (2007) 658-676
4. Almond C.S., Thiagarajan R.R., Piercey G.E., et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 119 (2009) 717-727
5. Rupp S., Bauer J., Tonn T., et al. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy. Pediatr Transplant 13 (2009) 620-623
6. Akintuerk H., Michel-Behnke I., Valeske K., et al. Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation 105 (2002) 1099-1103
7. Assmus B., Schachinger V., Teupe C., et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
8. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
9. Lange R., Vogt M., Horer J., et al. Long-term results of repair of anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg 83 (2007) 1463-1471
10. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
11. Dimmeler S., Burchfield J., and Zeiher A.M. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 28 (2008) 208-216
12. Dimmeler S., Zeiher A.M., and Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115 (2005) 572-583
13. Rupp S., Koyanagi M., Iwasaki M., et al. Genetic proof-of-concept for cardiac gene expression in human circulating blood-derived progenitor cells. J Am Coll Cardiol 51 (2008) 2289-2290
14. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
15. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
16. Diller G.P., van Eijl S., Okonko D.O., et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation 117 (2008) 3020-3030
17. Bahlmann F.H., De Groot K., and Spandau J.M. Erythropoietin regulates endothelial progenitor cells. Blood 103 (2004) 921-926
18. Aicher A., Zeiher A.M., and Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 45 (2005) 321-325